title: Effect of inhaled ingredients of a commercial cyclosporin A ampoule on airway inflammation.
authors.forename: B
authors.initials: B
authors.lastname: Ceyhan
authors.forename: M
authors.initials: M
authors.lastname: Sungur
authors.forename: C A
authors.initials: CA
authors.lastname: Celikel
authors.forename: T
authors.initials: T
authors.lastname: Celikel
mesh_terms: D000280:Administration, Inhalation; D000818:Animals; D001249:Asthma / Q000276:immunology; D001980:Bronchi / Q000187:drug effects* / Q000276:immunology; D016535:Bronchial Hyperreactivity / Q000188:drug therapy* / Q000276:immunology; D001992:Bronchoalveolar Lavage Fluid / Q000166:cytology; D016572:Cyclosporine / Q000008:administration & dosage*; D004195:Disease Models, Animal; D004804:Eosinophils / Q000187:drug effects; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007249:Inflammation / Q000188:drug therapy / Q000276:immunology; D007958:Leukocyte Count / Q000187:drug effects; D010047:Ovalbumin; D051381:Rats
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D010047:Ovalbumin